Staff

AIM ImmunoTech Highlights Start of Recruitment in Roswell Park Clinical Trial Incorporating Ampligen in the Treatment of Cancer Patients with Mild or Moderate COVID-19

OCALA, FL / ACCESSWIRE / September 16, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announced that recruitment has begun...

Vibrent Health Wins NIH Contract to Develop Powerful New Digital Health Solutions for COVID-19 Contact Tracing to Reduce the Risk of Infection and Help Society Return to Normal Activities

Vibrent’s Digital Health Solutions Platform to play major role in COVID-19 recovery efforts through smart device integration, privacy protection, health...

error: Content is protected !!